Former Genzyme exec Vivaldi heads to Philadephia rare disease biotech
December 16, 2014 at 11:26 AM EST
Former Genzyme executive Rogerio Vivaldi, who spent the past year overseeing the initial public offering of Minevra Neurosciences, is back to focusing on rare diseases with a new job at a Philadelphia-based biotech...